Buy the dip: Wall Street sell-off presents opportunity JPM

11:13pm, Monday, 10'th Jan 2022 FX Empire
By Stephen Culp NEW YORK (Reuters) Marko Kolanovic, chief global markets strategist at JPMorgan Chase & Co, believes Wall Streets recent sell-off presents a buying opportunity.
I posted on this back on January 3. Now, I''d love to take the credit for getting in before JPMorgan saying ''buy the dip'' earlier today: JP Morgan''s Kolanovic says it''s time to buy the dip But, the thing is, JPM were the ones with the front-running ahead of advice from JPM. Here''s the pos

Car-sharing company Turo files for IPO

10:12pm, Monday, 10'th Jan 2022 MarketWatch
Peer-to-peer car-sharing company Turo has filed for an initial public offering, according to a filing late Monday. Turo, based in San Francisco, filed to sell up to $100 million worth of shares, although that figure is often a placeholder used to calculate fees. The company plans to list its stock on the New York Stock Exchange under the symbol TURO, and underwriters include JPMorgan and Morgan Stanley. "Our mission is to put the world''s 1.5 billion cars to better use," Turo said in its prospectus, adding that its business is "resilient" as it "dynamically adjusts" to the needs of car owners and car renters. For the nine months ended on Sept. 30, Turo had sales of $330.5 million, up 207% from sales of $107.8 million for the same period in 2020, the company said. Net loss rose to $129.3 million, from $51.7 million for the same period in 2020. After a record-shattering 2021, the IPO market is expected to welcome companies such as grocery-delivery service Instacart, data-analytics company Databricks, and retailer Mattress Firm this year.
Citius, Altius, Debilius: Dip-Buyers Rescue Tech-Wreck As Rate-Hike-Odds Soar If the market is to be believed, Fed rates are going higher, faster, and sooner than anyone expected while the economy (and the market) are weaker than most expected and inflation dramatically higher than every establishment groupthinker could imagine... March rate-hike odds are over 90%... Source: Bloomberg And the market is pricing in 4 rate-hikes this year... Source: Bloomberg All of which combined to send stocks down on the day, but that wouldn''t last! Today''s BTFD bounce came at the Nasdaq 200DMA and coincided with JPM''s Kolanovic urging its clients to BTFD once again ... Nasdaq recovered from a 2.7% intraday loss to close green Nasdaq was down over 7% YTD at its lows today (and Small Caps -5% YTD)... The Nasdaq bounced at its 200DMA today... After it briefly entered into ''correction'', down 10% from record highs... "...the music is about to stop and we''re going to be left holding the biggest bag of odorous excrement in the history of capitalism..." Unprofitable tech stocks are down 48% from their record highs...
JPMorgan reiterates a Buy rating on Solo Brands and sets a December 2022 price target to $27 after taking in the retailer''s ICR presentation and guidance. Read more.

JPMorgan 40th Annual Healthcare Conference Slide

08:31pm, Monday, 10'th Jan 2022 Seeking Alpha
Following is the unofficial transcript of a CNBC interview with JPMorgan Chase & Co. (NYSE:JPM) Chairman & CEO Jamie Dimon on CNBCs The Exchange (M-F, 1PM-2PM ET) today, Monday, January 10th. Following are links to video on CNBC.com: Q4 2021 hedge fund letters, conferences and more The Consumer Balance Sheet Has Never Been In Better []
Biogen Touts Alzheimer''s Drug Price-Cut As It Begs Wall Street To Give It Another Chance Looks like Biogen''s "shot at redemption" maybe might work out - although the firm isn''t out of the woods yet, not by a long shot. Biogen shares memorably surged after the FDA approved Aduhelm, the company''s "breakthrough" Alzheimer''s drug, back in June. But practically ever since, the drug has been dogged by controversy (for example, the Europeans have more or less rejected it, and three FDA advisors quit to protest the fact that it had won approval). The head of the FDA has since called an investigation , and it remains to be seen whether the drug''s approval will ultimately be walked back. Biogen cut its price for the drug in December, as a number of medical systems have declined to offer it, causing sales to dramatically disappoint Wall Street expecpectations. But on Monday, the company got a shot at redemption when it delivered a presentation at a JP Morgan health-care conference that was one of the other major events on the day''s agenda to distract from the worsening market rout.

JPMorgan CEO says 2022 could bring more than four rate hikes

07:06pm, Monday, 10'th Jan 2022 Investing.com
https://www.investing.com/news/economy/jpmorgan-ceo-says-2022-could-bring-more-than-four-rate-hikes-2734997

JP Morgan''s Kolanovic says it''s time to buy the dip

05:18pm, Monday, 10'th Jan 2022 Forexlive
The last time we heard from JP Morgan uber-quant Marko Kolanovic was in early October when the world was full of fear. At the time he said it was time to buy the dip because fears of higher yields were overdone. He said the market could absorb higher yields. "We don''t expect a broad market

Key Events In The "Massive Week Ahead"

02:24pm, Monday, 10'th Jan 2022 Zero Hedge
Key Events In The "Massive Week Ahead" After a relatively quiet start to the year on the economic event front, if not in markets where last week''s FOMC Minutes sparked the worst bond rout since 2020 triggering the worst first week for the Nasdaq since the dot com bubble burst ... we have a "simply a massive week ahead for markets" according to Nomura''s Charlie McElligott, with Powell testimony and bunches of Fed speakers, along with US economic releases headlined by the markets most important datapoint in the CPI release Wednesday, in addition to PPI, Retail Sales and Consumer Sentiment over the course of the week, plus two Duration-heavy auctions ($36B of 10Y and $22B 30Y, on top of tomorrows $52B 3Y) and finally, US corporate earnings season kickoff (highlighted by JPM, C and WFC this upcoming Friday) Picking up the weekly preview baton, Rabobank writes that there will be little opportunity not to think about the Fed in the week ahead. The Bloomberg market consensus for Wednesdays US December CPI inflation release stands at an astounding 7% y/y.
About a fifth of its new hires will focus on clients in mainland China, the people added, which is among the fastest growing wealth markets globally despite an unprecedented regulatory crackdown that has clouded its economic prospects
These Are The Three Things Investors Will Focus On During Q4 Earnings Season And Into 2022 There are no two ways about it: the first full year of the year was a lousy one for stocks, with the S&P falling by 1.9% and the Nasdaq tumbling 3.5%, its biggest drop since the year 2000 - the year the dot com bubble popped. The culprit for the plunge, of course, was the Fed, with the mid-week pivot coinciding with the release of the hawkish December FOMC minutes that hinted at not just a faster liftoff, but an even faster balance sheet drawdown. As a result, banks expect the Fed to hike either three or four times, with some expecting the Fed to announce QT in early H2, and Friday''s dismal jobs report which showed just 199K gains (vs. consensus of 450K) did not deter hawkish expectations as the unemployment rate - just a few years ago viewed as a completely meaningless statistic - fell to 3.9%, down 0.3% from 4.2% in November. Looking at the price action, Goldman''s David Kostin - who is of course, head of research and not an actual trader - points to the rapid move higher in yields catalyzed by the Fed statement, and which surged as high as 1.80% last week before settling around 1.76% after ending 2021 at 1.52%, a 24 bps rise over just 5 days.
"In 10 Years Half Of All Financial Transactions Will Touch Ethereum" - Iconic Crypto Fund Responds To JPMorgan''s Ethereum Hit Piece Perhaps having grown tired of bashing bitcoin which had become one of his main pastimes for the past two years, JPMorgan quant (and rising in-house expert cryptoskeptic) Nick Panigirtzoglou shifted his attention to ethereum last week, and at the risk of infuriating his (very wealthy) web 3.0 clients, used his latest Flows and Liquidity report to slam the second biggest cryptocurrency by warning that it has "been losing market share in the DeFi space at a rapid pace over the past year." And while he admits that the pace has (clearly) slowed in the second half of the year (as the chart below so vividly demonstrates), he then boldly predicts that "the share of ethereum in DeFi will likely drop further before Sharding is implemented in 2023" although it is very much unclear how he reaches this conclusion, and then proceeds to note that "the relative valuation of ethereum vs. its competitors has been echoing its declining DeFi share", because correlation in this case is clearly causation.
The Q4 earnings season will begin next week with some of the largest banks and financial firms.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE